Literature DB >> 1323062

Structure of an SH2 domain of the p85 alpha subunit of phosphatidylinositol-3-OH kinase.

G W Booker1, A L Breeze, A K Downing, G Panayotou, I Gout, M D Waterfield, I D Campbell.   

Abstract

Receptor protein-tyrosine kinases, through phosphorylation of specific tyrosine residues, generate high-affinity binding sites which direct assembly of multienzyme signalling complexes. Many of these signalling proteins, including phospholipase C gamma, GTPase-activating protein and phosphatidylinositol-3-OH kinase, contain src-homology 2 (SH2) domains, which bind with high affinity and specificity to tyrosine-phosphorylated sequences. The critical role played by SH2 domains in signalling has been highlighted by recent studies showing that mutation of specific phosphorylation sites on the platelet-derived growth factor receptor impair its association with phosphatidylinositol-3-OH kinase, preventing growth factor-induced mitogenesis. Here we report the solution structure of an isolated SH2 domain from the 85K regulatory subunit of phosphatidylinositol-3-OH kinase, determined using multidimensional nuclear magnetic resonance spectroscopy. The structure is characterized by a central region of beta-sheet flanked by two alpha-helices, with a highly flexible loop close to functionally important residues previously identified by site-directed mutagenesis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1323062     DOI: 10.1038/358684a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  43 in total

1.  Alternative modes of binding of proteins with tandem SH2 domains.

Authors:  R O'Brien; P Rugman; D Renzoni; M Layton; R Handa; K Hilyard; M D Waterfield; P C Driscoll; J E Ladbury
Journal:  Protein Sci       Date:  2000-03       Impact factor: 6.725

2.  Fluorescence intensity multiple distributions analysis: concurrent determination of diffusion times and molecular brightness.

Authors:  K Palo; U Mets; S Jäger; P Kask; K Gall
Journal:  Biophys J       Date:  2000-12       Impact factor: 4.033

3.  Reconstitution of a native-like SH2 domain from disordered peptide fragments examined by multidimensional heteronuclear NMR.

Authors:  D D Ojennus; M R Fleissner; D S Wuttke
Journal:  Protein Sci       Date:  2001-11       Impact factor: 6.725

Review 4.  The phospholipase C isozymes and their regulation.

Authors:  Aurelie Gresset; John Sondek; T Kendall Harden
Journal:  Subcell Biochem       Date:  2012

5.  Electrostatic interactions in the reconstitution of an SH2 domain from constituent peptide fragments.

Authors:  Deanna Dahlke Ojennus; Sarah E Lehto; Deborah S Wuttke
Journal:  Protein Sci       Date:  2003-01       Impact factor: 6.725

6.  Random-coil behavior and the dimensions of chemically unfolded proteins.

Authors:  Jonathan E Kohn; Ian S Millett; Jaby Jacob; Bojan Zagrovic; Thomas M Dillon; Nikolina Cingel; Robin S Dothager; Soenke Seifert; P Thiyagarajan; Tobin R Sosnick; M Zahid Hasan; Vijay S Pande; Ingo Ruczinski; Sebastian Doniach; Kevin W Plaxco
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-16       Impact factor: 11.205

7.  Induced alignment and measurement of dipolar couplings of an SH2 domain through direct binding with filamentous phage.

Authors:  D Dahlke Ojennus; R M Mitton-Fry; D S Wuttke
Journal:  J Biomol NMR       Date:  1999-06       Impact factor: 2.835

8.  Solution structure of the human Grb7-SH2 domain/erbB2 peptide complex and structural basis for Grb7 binding to ErbB2.

Authors:  Monika Ivancic; Roger J Daly; Barbara A Lyons
Journal:  J Biomol NMR       Date:  2003-11       Impact factor: 2.835

9.  Association of hematopoietic cell phosphatase with c-Kit after stimulation with c-Kit ligand.

Authors:  T Yi; J N Ihle
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

10.  Distinct p53/56lyn and p59fyn domains associate with nonphosphorylated and phosphorylated Ig-alpha.

Authors:  C M Pleiman; C Abrams; L T Gauen; W Bedzyk; J Jongstra; A S Shaw; J C Cambier
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.